Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

539 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Elevated serum IP-10 levels observed in type 1 diabetes.
Shimada A, Morimoto J, Kodama K, Suzuki R, Oikawa Y, Funae O, Kasuga A, Saruta T, Narumi S. Shimada A, et al. Among authors: oikawa y. Diabetes Care. 2001 Mar;24(3):510-5. doi: 10.2337/diacare.24.3.510. Diabetes Care. 2001. PMID: 11289477
Detection of GAD-reactive CD4+ cells in so-called "type 1B" diabetes.
Shimada A, Kodama K, Morimoto J, Oikawa Y, Irie J, Nakagawa Y, Matsubara K, Maruyama T, Saruta T. Shimada A, et al. Among authors: oikawa y. Ann N Y Acad Sci. 2003 Nov;1005:378-86. doi: 10.1196/annals.1288.063. Ann N Y Acad Sci. 2003. PMID: 14679096
The role of the CXCL10/CXCR3 system in type 1 diabetes.
Shimada A, Oikawa Y, Yamada Y, Okubo Y, Narumi S. Shimada A, et al. Among authors: oikawa y. Rev Diabet Stud. 2009;6(2):81-4. doi: 10.1900/RDS.2009.6.81. Epub 2009 Aug 10. Rev Diabet Stud. 2009. PMID: 19806237 Free PMC article.
Effect on the atherogenic marker plasminogen activator inhibitor type-1 of addition of the ACE inhibitor imidapril to angiotensin II type 1 receptor antagonist therapy in hypertensive patients with abnormal glucose metabolism: a prospective cohort study in primary care.
Yajima K, Shimada A, Hirose H, Oikawa Y, Yamada S, Meguro S, Irie J, Irie S. Yajima K, et al. Among authors: oikawa y. Clin Drug Investig. 2009;29(12):811-9. doi: 10.2165/11530610-000000000-00000. Clin Drug Investig. 2009. PMID: 19888787
539 results